Exhaled VOCs to differentiate between genetic variants in patients with PCD - Amsterdam 2025

Bronchiectasis: precision approaches and complex phenotypes

Chair(s): Kathryn Ramsey, Rosanel Amaro Rodriguez

Session type: Poster session

Exhaled VOCs to differentiate between genetic variants in patients with PCD

Obbe Sammels

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Twelve weeks treatment of roflumilast in bronchiectasis - Anti-inflammatory effects and clinical benefits

Wang Chun Kwok

Poster

Abstract

Targeting hemoptysis in bronchiectasis: exploring treatable traits

Lê Qu?c Khánh Tr?n

Poster

Abstract

Clinical profile and mutation spectrum of molecularly confirmed patients with Primary Ciliary Dyskinesia

Barney Isaac

Poster

Abstract

Gastro-oesophageal reflux disease influences disease severity in non-cystic fibrosis bronchiectasis patients without asthma

Giuseppina Angileri

Poster

Abstract

Predictors of Inhaled Antibiotic Intolerance in Chronic Bronchial Infection: A Multicenter Study in Spain

Carlos Manzano Senra

Poster

Abstract

Preliminary efficacy of Tezepelumab in patients with clinically significant bronchiectasis and severe asthma An Italian multicentric observational study

Giacomo Maruca

Poster

Abstract

Addressing the clinical heterogeneity of bronchiectasis exacerbations: a multicentre, cross-sectional study.

Angela Tramontano

Poster

Abstract

Correlation between chest CT features and clinical and biological data in patients with bronchiectasis

Soumaya Debiche

Poster

Abstract

Exhaled VOCs to differentiate between genetic variants in patients with PCD

Obbe Sammels

Poster

Abstract

Trajectory of lower airway bacterial colonization in patients with primary ciliary dyskinesia

Benoît Douvry

Poster

Abstract

Phenotype Analysis of Chronic Bronchial Infection Patients on Inhaled Antibiotic Therapy: A Multicentre Retrospective Cohort Study in Spain (INBREATHING Study)

Beatriz Raboso Moreno

Poster

Abstract

Adjudication of pulmonary exacerbations in bronchiectasis using the EMBARC consensus exacerbation criteria: data from the CLEAR Trial

Brenda O'neill

Poster

Abstract

Prevalence and characterization of pulmonary manifestations in inflammatory bowel diseases (IBDs).

Chiara Contin

Poster

Abstract

Respiratory burden in hematology-related bronchiectasis: clinical characteristics and treatable traits

Ophir Freund

Poster

Abstract

Characteristics of bronchiectasis patients diagnosed with cystic fibrosis (CF) in adulthood

Colm Kennedy

Poster

Abstract

Is CFAP53 a cause of primary ciliary dyskinesia (PCD)?

Gemma Fryatt

Poster

Abstract

Pleuroparenchymal fibroelastosis prevalence in bronchiectasis: preliminary data of a multicentre study

Francesca Gonnelli

Poster

Abstract

Automatic bronchus artery and mucus plug analysis of adult bronchiectasis disease patients treated with dornase alfa

Federico Mollica

Poster

Abstract

Role of Pseudomonas Aeruginosa Mucoid and Non-Mucoid Phenotypes in Bronchiectasis: A Descriptive Study.

Jorge Mora

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}